APOC Wire

Japan-Made Premium NMN Supplement “NMN Kiwami,” Fully Certified by the FDA and Backed by Clinical Data, Launches Strategic Partnerships with Major U.S. Distributors

by ASA Pharmaceutical Co. Ltd. March 3, 2026 10:00

“NMN Kiwami,” a Japan-made NMN supplement that meets FDA standards and is supported by clinical data demonstrating telomere length extension, is now seeking strategic partners for expansion across North America. Trusted by medical institutions in Japan for professional use and as a raw material for NMN IV therapy, and backed by a 95% repeat purchase rate, NMN Kiwami offers distributors a fully compliant, evidence-based NMN product to strengthen their wellness portfolios.

ASA Pharmaceutical Co. Ltd. announced that starting Monday, January 26, 2026, it will significantly strengthen its supply system for the North American market for its Japan-made NMN supplement “NMN Kiwami,” which is certified by the FDA and supported by clinical evidence. At the same time, the company has officially begun recruiting local sales distributors in the United States.

Due to its exceptional quality, NMN Kiwami is distributed exclusively through medical institutions in Japan and is also used as a raw material for NMN intravenous therapy, positioning it as a professional-grade product. With a remarkable 95% repeat usage rate, NMN Kiwami enters the rapidly expanding U.S. longevity market by leveraging its unique combination of advanced Japanese manufacturing technology and strict compliance with U.S. regulatory standards. Together with strategic local partners, ASA Pharmaceutical aims to further expand market share in North America.

Four Reasons Why U.S. Distributors Should Choose “NMN Kiwami”

Reason 1: Exceptional Compliance and Safety (FDA & Informed Sport)
Regulatory compliance is the highest barrier in the U.S. supplement market. NMN Kiwami uses Japan-produced NMN that meets FDA standards. In addition, it has obtained Informed Sport certification, which complies with standards set by the World Anti-Doping Agency (WADA). This allows distributors serving professional athletes and celebrities to add NMN Kiwami to their product lineup with confidence and minimal risk.

Reason 2: Reliability Based on Clinical Evidence
Rather than relying solely on theoretical claims, NMN Kiwami has undergone human clinical trials involving subjects aged 50 to 61. The results confirmed improvements in insulin resistance and triglyceride levels, as well as an increase in telomere length, a recognized marker of aging. These clinically validated outcomes serve as a powerful sales point for evidence-driven, high-income consumers in the U.S. market.

Reason 3: “Made in Japan” Quality and Advanced Delivery Technology

  • 100% Pure, Japan-Made NMN: A proprietary manufacturing process achieves high NMN content per capsule with zero impurities.
  • Acid-Resistant HPMC Capsules: Special capsules protect NMN from stomach acid and deliver it effectively to the small intestine.
  • PTP Blister Packaging: Maintains NMN quality at the highest level until the moment of use, protecting it from oxidation.

Reason 4: Presentation at the Japanese Society of Anti-Aging Medicine and Physician Supervision
Supervised by Dr. Hibino, a leading authority in anti-aging medicine, NMN Kiwami has had its research findings presented at the General Meeting of the Japanese Society of Anti-Aging Medicine. With strong academic backing, the product is well suited for expansion into wellness clinics, spas, and premium fitness chains.

Support System for Local Distributors

  • Stable Supply: Strengthened in-house production lines allow flexible 대응 to large-volume orders
  • Marketing Support: Provision of clinical trial data, high-resolution product visuals, and physician endorsement comments
  • Exclusive Distribution Rights: Discussions regarding regional exclusivity based on performance and territory
  • Optimized Logistics: Documentation support for international shipping, including certificates of origin

Comment from CEO Tomoko Iwase
“We firmly believe that Japan’s precise manufacturing technology can deliver new value to health-conscious consumers in the United States. ‘NMN Kiwami’ is not just a supplement—it represents a science-based approach to well-aging. Together with U.S. partners who share this vision, we aim to create the next generation of the global health market.”

Company Profile
Company Name: ASA Pharmaceutical Co. Ltd.
Location: Minato-ku, Tokyo, Japan
Representative: CEO Tomoko Iwase
Business Description: Manufacture and sales of supplements; development and sales of cosmetics
Official Website: https://asapharma.jp/